SHAMSAD BEGUM: Open Payments
NPI 1386629673 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$855 in 30 payments from 14 companies in 2025. Trend: 2023 $762 · 2024 $615 · 2025 $855
Food & beverage: $817Education: $38
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 2 | $150 |
| Novo Nordisk Inc | 2 | $139 |
| Lundbeck LLC | 6 | $118 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $113 |
| Exact Sciences Corporation | 3 | $70 |
| UCB, Inc. | 2 | $53 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Mannkind Corporation | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
Products named: DAYBUE, Ozempic, REXULTI, CAPLYTA, Cologuard Collection Kit, JARDIANCE, TRELEGY ELLIPTA, Briviact.
Industry payments across FL — which companies pay providers there.
